Development of Potent and Selective Janus Kinase 2/3 Directing PG–PROTACs | ACS Medicinal Chemistry Letters
Introducing the Tellurophene-Appended BODIPY: PDT Agent with Mass Cytometry Tracking Capabilities | ACS Medicinal Chemistry Letters
Profiling and Application of Photoredox C(sp3)–C(sp2) Cross-Coupling in Medicinal Chemistry | ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters Template - American Chemical Society
ACS Medicinal Chemistry Letters Template - American Chemical Society
ACS Medicinal Chemistry Letters | Vol 11, No 10
Featured Letter in ACS Medicinal Chemistry Letters – NITSCHE LAB
ACS medicinal chemistry letters template – ScienceIn Publishing
Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation | ACS Medicinal Chemistry Letters
Senior Scientist Medicinal Chemistry Cover Letter Sample | Kickresume
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists | ACS Medicinal Chemistry Letters
Structural Rigidification of N-Aryl-pyrroles into Indoles Active against Intracellular and Drug-Resistant Mycobacteria | ACS Medicinal Chemistry Letters
Design, Synthesis, and Evaluation of Donepezil-Like Compounds as AChE and BACE-1 Inhibitors | ACS Medicinal Chemistry Letters
LaTeX Templates - American Chemical Society (ACS) Publications
ACS Medicinal Chemistry Letters Template - American Chemical Society
LaTeX Templates - American Chemical Society (ACS) Publications
ACS Medicinal Chemistry Letters Template - American Chemical Society
Evaluation of Oxetan-3-ol, Thietan-3-ol, and Derivatives Thereof as Bioisosteres of the Carboxylic Acid Functional Group | ACS Medicinal Chemistry Letters
ACS Division of Medicinal Chemistry
Expanding the Medicinal Chemist Toolbox: Comparing Seven C(sp2)–C(sp3) Cross-Coupling Methods by Library Synthesis | ACS Medicinal Chemistry Letters
Publications – Gavande Lab
MK-7622: A First-in-Class M1 Positive Allosteric Modulator Development Candidate | ACS Medicinal Chemistry Letters
Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637) | ACS Medicinal Chemistry Letters
